Skip to content

Immatics

US · IMTX #3173 by market cap Listed 2018
7.45 -0.05 -0.67%
Live - 5344 symbols - heartbeat 289s ago · 2026-10-08 05:54
Pre-market 7.40 -0.67%
After-hours 7.88 +5.77%
Overnight 7.46 +0.13%
Market cap
1.11B
P/B
2.49
EPS
-1.80
Reader sentiment Are you bullish or bearish on IMTX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.6 percentage points.

Institutional ownership

Held by institutions
85.37% -1.62pp
Institutions
93 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Hedge Fund34.25%
VC/PE Fund21.80%
Mutual Fund21.57%
Public Company6.76%
Individual/Insider3.45%
Government Pension Fund0.51%
Private Company0.46%
Other11.19%

Top holders as of 2026-06-30

T. Rowe Price Group, Inc. 16.66% · 22.78M sh
dievini Hopp BioTech holding GmbH & Co. KG 10.90% · 14.90M sh
RTW Investments, LP 9.47% · 12.95M sh
Perceptive Advisors LLC 8.19% · 11.20M sh
Montanova Capital, LLC 8.19% · 11.19M sh
Baker Bros. Advisors LP 6.96% · 9.51M sh
Jefferies Financial Group Inc. 4.76% · 6.51M sh
Vestal Point Capital, LP 4.52% · 6.18M sh
Sofinnova Investments, Inc. 2.68% · 3.67M sh
Morgan Stanley 1.59% · 2.17M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

40 filings tracked · 12 buys · 0 sells

NameRoleStake
Mathias Hothum Non-Executive Director 0.24%
Harpreet Singh CEO, MD, Member of Management Board & Executive Director 0.16%
Michael Atieh Independent Non-Executive Director 0.10%
Paul Carter Independent Non-Executive Director 0.10%
Heather Mason Independent Vice Chair of the Board of Directors 0.10%
Eliot Forster Independent Non-Executive Director 0.10%
Adam Stone Independent Non-Executive Director 0.10%
Peter Chambré Non-Executive Chairperson 0.08%
Carsten Reinhardt Chief Development Officer 0.03%
Alise Reicin Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-25 Perceptive Advisors LLC -- Private Acquisition +863,060 $8.69
2026-08-13 James Pepin General Counsel Other Derivative Acquisition +43,800 --
2026-08-13 James Pepin General Counsel Other Derivative Acquisition +181,200 $9.44
2026-06-15 Michael Atieh Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09
2026-06-15 Peter Chambré Non-Executive Chairperson Other Derivative Acquisition +48,000 $9.09
2026-06-15 Heather Mason Independent Vice Chair of the Board of Directors Other Derivative Acquisition +48,000 $9.09
2026-06-15 Perceptive Advisors LLC -- Other Derivative Acquisition +48,000 $9.09
2026-06-15 Eliot Forster Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09
2026-06-15 Paul Carter Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09
2026-06-15 Mathias Hothum Non-Executive Director Other Derivative Acquisition +48,000 $9.09
2026-06-15 Alise Reicin Director Other Derivative Acquisition +48,000 $9.09
2026-06-15 Adam Stone Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09
2026-03-17 Michael Atieh Independent Non-Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Peter Chambré Non-Executive Chairperson Initial Statement of Beneficial 0 --
2026-03-17 Heather Mason Independent Vice Chair of the Board of Directors Initial Statement of Beneficial 0 --
2026-03-17 Perceptive Advisors LLC -- Initial Statement of Beneficial 0 --
2026-03-17 Harpreet Singh CEO, MD, Member of Management Board & Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Carsten Reinhardt Chief Development Officer Initial Statement of Beneficial 0 --
2026-03-17 Eliot Forster Independent Non-Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Paul Carter Independent Non-Executive Director Initial Statement of Beneficial 0 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 05:54:03 · For reference only, not investment advice and not tailored to your situation.